BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
Offered by Amyotrophic Lateral Sclerosis Assn · Arlington, VA
About this opportunity
This NIH funding opportunity seeks to encourage applicants to pursue milestone-driven first-in-human or early stage clinical investigations of devices with recording and/or stimulation capabilities that advance clinical diagnostic or therapeutic applications. Funding will support a small clinical study to answer key questions about device function or final design.
How to apply
Applications are handled on the funder's own website. Review the full guidelines and apply here: als.org/research/researchers/research-funding-opportunities. Confirm the deadline and eligibility directly with Amyotrophic Lateral Sclerosis Assn before applying.
See Amyotrophic Lateral Sclerosis Assn's full giving profile — its grant history, top recipients, and other funding priorities.
Is this grant a fit for your nonprofit?
Before you spend hours on an application, know whether it's worth it. Bespoke Grants scores any open RFP against your mission, budget, and service area — and finds the other funders you're missing. Free, no credit card.
Check my fit & find more grants →Other open opportunities from Amyotrophic Lateral Sclerosis Assn
Amyotrophic Lateral Sclerosis Assn currently lists 6 open opportunities in our index.
- BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18)
- BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)
- Clinical Repurposing Research to Impact Veterans/Military
- Identify and Evaluate Potential Risk Factors for ALS
- Drs. Ayeez and Shelena Lalji & Family Student Scholar Award for Repair and Regenerative Mechanisms in ALS
Frequently asked questions
- What is the deadline for BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)?
- The application deadline is September 28, 2026. Deadlines can change — always confirm directly with Amyotrophic Lateral Sclerosis Assn before applying.
- How much funding is available?
- The award range is Up to $1.5M.
- Where do I apply?
- Applications are submitted through Amyotrophic Lateral Sclerosis Assn's own website or process — see the "How to apply" section above.